Screener
ArriVent BioPharma, Inc. AVBP Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from ArriVent BioPharma, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-058650
FAQ
- What is ArriVent BioPharma, Inc.'s return on equity?
- ArriVent BioPharma, Inc. (AVBP) reported return on equity of -55.2% in Q1 2026.
- How has ArriVent BioPharma, Inc.'s return on equity changed year-over-year?
- ArriVent BioPharma, Inc.'s return on equity decreased by 12.6% year-over-year, from -49% to -55.2%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about ArriVent BioPharma, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude